Silica-challenged macrophage secretome drives distinct alveolar and bronchial epithelial-fibroblast crosstalk: a multicellular preclinical modelling approach

Silicosis is a relentless lung disease caused by breathing in tiny, sharp particles of crystalline silica, the same material found in sand, stone, and concrete. When these particles settle deep in the lungs, the body's immune system sends out specialized cells called macrophages to clean them up. However, the silica is too sharp to be digested, and the immune cells end up dying in the process, releasing a toxic cocktail of chemicals that triggers chronic inflammation. This persistent signal causes the lung's lining to break down and the tissue to harden into scar tissue, a process known as fibrosis. For decades, scientists have tried to understand exactly how this chain reaction works and how to stop it, but they have faced a difficult choice in how to study it. Traditional lab experiments using cells spread flat on plastic dishes often fail to capture the complex, three-dimensional structure of real lung tissue, while experiments on animals often produce results that do not translate well to humans due to differences in anatomy and breathing patterns.

To bridge this gap, a team of researchers at the Asbestos and Dust Diseases Research Institute in Australia developed a new way to model the disease using human cells arranged in a way that mimics the lung's natural architecture. Instead of looking at cells in isolation, they built small, three-dimensional spheres of cells and also created layered systems where different cell types sit above and below one another, allowing them to communicate through chemical signals without touching. Their goal was to see how the toxic signals released by silica-challenged immune cells affect the lung's lining and the cells that build its support structure, and whether the physical arrangement of these cells changes the outcome. By comparing these complex models to simpler, flat ones, the researchers hoped to uncover details about the disease that were previously invisible.

The researchers began by training a specific type of human immune cell to act like the macrophages found in the lungs. They exposed these cells to silica particles of two different sizes, measuring how the particles affected the cells' health and what chemicals they released. They found that the smaller silica particles were more damaging, causing the immune cells to release a high volume of inflammatory signals. The team then collected the liquid surrounding these stressed immune cells, which contained the toxic cocktail of chemicals, and used it to treat other human lung cells. They tested this mixture on two types of lung cells: alveolar cells, which line the tiny air sacs where oxygen exchange happens, and bronchial cells, which line the larger airways. They observed these cells in three different setups: flat on a dish, grouped into three-dimensional spheres, and arranged in a layered system where the lung cells sat on a mesh above the immune cells.

When the researchers applied the toxic immune signals to the flat, two-dimensional cultures, they saw a clear difference between the two types of lung cells. The alveolar cells became less healthy and showed signs of increasing inflammation over time. In contrast, the bronchial cells remained largely stable, with their inflammation levels returning to normal after a few days. However, when the researchers moved to the three-dimensional sphere models, the picture became more complex and revealing. The alveolar cells in the spheres showed a significant drop in health and a strong, sustained inflammatory response. More importantly, these cells began to change their identity, showing signs of a process called epithelial-mesenchymal transition, where they start to behave more like the cells that build scar tissue. The bronchial cells in the spheres also showed some of these changes, but they were less severe and appeared mostly at the genetic level rather than in the physical structure of the cells.

The most striking results emerged when the researchers added fibroblasts, the cells responsible for building the lung's structural framework, into the mix. In the three-dimensional spheres containing both lung cells and fibroblasts, the alveolar cells drove a powerful reaction. The presence of the toxic immune signals caused the fibroblasts to become highly active, producing large amounts of proteins that build scar tissue. This suggests that the alveolar cells act as a strong amplifier, turning a local immune reaction into a widespread fibrotic response. The bronchial cells, even when paired with fibroblasts, did not trigger the same intense reaction; their fibroblast partners remained relatively calm, producing only modest amounts of scar-building proteins. This difference highlights that the specific type of lung cell involved in the injury dictates how severe the resulting scarring will be.

To further understand how these cells talk to each other without touching, the team used a layered system where the lung cells sat on a porous membrane above the fibroblasts. This setup allowed chemicals to pass between the layers while keeping the cells physically separate. Even though the fibroblasts were never directly exposed to the toxic immune signals, they reacted strongly when the lung cells above them were treated. The lung cells, sensing the danger, released their own signals that traveled down to the fibroblasts, telling them to start building scar tissue. This confirmed that the lung cells act as a middleman, translating the initial immune attack into a message that instructs the structural cells to remodel the tissue. The alveolar cells sent a much louder message than the bronchial cells, leading to a more aggressive activation of the fibroblasts.

The study concludes that the physical arrangement of cells matters immensely when studying lung diseases like silicosis. The simple, flat models used in many previous studies failed to capture the full intensity of the damage and the specific ways different lung cells interact. By using three-dimensional models that better reflect the real structure of the lung, the researchers were able to see that alveolar cells are far more vulnerable to silica-induced damage and are much more likely to drive the fibrosis process than bronchial cells. These findings suggest that the location of the injury within the lung determines the severity of the disease, with damage to the air sacs being the primary driver of scarring. The researchers propose that these complex, multi-cell models provide a more accurate platform for testing new treatments, offering a clearer view of how the disease progresses and how it might be stopped.